The following is a review of Nebula Genomics's Initial Coin Offering of the "N/A" token. Get information about the Nebula Genomics ICO including; start date, end date, financial information, whitepaper, team profile and other important information regarding this new token.

Innitial Coin Offering (ICO) Information

ICO NameNebula Genomics
SymbolN/A
Start DateTBA
End DateTBA
CountryUSA
PlatformEthereum
ICO Time
Unknown
Show All

The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.

A study using #genomic data to investigate the #genetics of male #infertility has found 22 new mutations that could potentially be causing the condition. This could help establish new diagnostic tests and lead to more personalized care for infertility. https://t.co/OfxUWhSje5

In collab with @EMDSerono, biopharma arm of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, we're offering free high-coverage germline and tumor whole-genome sequencing to select lung cancer patients. Follow link for chance to participate! @EMDGroup https://t.co/KUbyyjEhQL

Excited to collaborate with Inspire @teaminspire and use their network of patients and caregivers to help match patients with genomic studies such as our pilot collaboration with @EMDSerono. This will provide patients w/ valuable information while accelerating medical progress.

Blockchain firm Nebula Genomics to collaborate with Merck’s North American biopharmaceutical business
https://t.co/QLzgerh1CY

Merck subsidiary pilots bitcoin blockchain for genomic data: https://t.co/iyvGMBkjXx by @Rachelwolf00 via @Forbes

We’re proud to announce our pilot collab. with @EMDSerono, the biopharma arm of Merck KGaA, Darmstadt, Germany. To accelerate research and create targeted new medicines, we’re enabling individuals to share access to their genomic data through our platform. https://t.co/f9L6Geq3M6

Curious about how #GenomicMedicine will affect your life in the future? Learn more on our blog: https://t.co/qGFzpw99Ao #PrecisionMedicine #genomics

Congrats to our CEO @ObbadKamal and our founder @geochurch on being featured among the "Top 25 Voices in Precision Medicine"! #PrecisionMedicine @BISResearch

Load More News...
PriceN/A SaleN/A Payment ModeETH
Minimum InvestmentN/A DistributionN/A RaisedN/A
Soft CapN/A Hard CapN/A

Other Initial Coin Offerings To View